NSE · Healthcare · Drug Manufacturers - Specialty & Generic
| Document | Date |
|---|---|
| Annual report FY2026 SUMMARY: BAL PHARMA LIMITED - FY 2025-26 ANNUAL REPORT HEADLINE NUMBERS • Total Income (Standalone): Rs. 31,279.99 lakhs (FY 2025-26) vs Rs. 30,464. | 2026-08-26 |
| Quarterly results · Q1 FY27 BAL PHARMA LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026-27 (Quarter ended 30 June 2026) Standalone Revenue from Operations: ₹8,842.73 Lak | 2026-08-12 |
| Quarterly results | 2026-07-27 |
| Quarterly results · Q4 FY26 BAL PHARMA LIMITED – FINANCIAL SUMMARY HEADLINE NUMBERS • FY 2025-26 Revenue from Operations: Rs. 31,079.70 lakhs (vs Rs. 30,249.64 lakhs in FY 2024 | 2026-05-27 |
| Quarterly results · Q3 FY26 BAL PHARMA LIMITED – Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 FY2026 (Quarter ended 31-Dec-2025) Standalone Results: - Revenue from opera | 2026-02-11 |
| Quarterly results · Q2 FY26 BAL PHARMA LIMITED – DOCUMENT SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q2 FY2026 (Quarter ended 30 Sep 2025) – Standalone: - Revenue from o | 2025-11-12 |
| Annual report FY2025 BAL PHARMA LIMITED – ANNUAL REPORT FY 2024-25 SUMMARY HEADLINE NUMBERS • Dividend declared: Re.1.20 per Equity Share of Rs 10/- each • Financial yea | 2025-09-02 |
| Quarterly results · Q1 FY26 BAL PHARMA LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Q1 FY2026 Standalone Revenue: ₹6,563.51 lakhs (quarterly unaudited) • Q1 FY2026 Standalone | 2025-08-11 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1.20 / share ex-date Sep 17, 2026 | 2026-09-17 |
| Dividend | ₹1.20 / share ex-date Sep 18, 2025 | 2025-09-18 |
| Announcement | Date |
|---|---|
| Approved investment in proposed joint venture entity in Philippines Bal Pharma Limited's board approved five key decisions on August 12, 2026: 1. **Q1 FY2027 Results**: Approved unaudited financial results for the quarter ended June 30, 2026, with auditor's | 2026-08-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bal Pharma Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.